Medicinal cannabis and cosmetics firm MGC Pharmaceuticals has won approval from the US regulator to sell its cannabis-based anti-ageing cosmetics in America.
MGC says approval from the US Food and Drug Administration (FDA) marks the company's entry into the $US11 billion ($A15.32 billion) US skin care market.
The company also said it had made its first US sale, through a new distribution deal with California's C&M CBD Holding for cannabis-based cosmetic products.
MGC is seeking other distribution partners in key US states.
The firm said FDA approval for the first 16 of its products means its cannabis-based cosmetics can be imported and sold throughout the USA, even in states where medicinal cannabis is not yet legal.
Read more
